Design and in vivo evaluation of a patch system based on thiolated polymers

Journal of Pharmaceutical Sciences

Volumn 98, Issue 2, 2009, Pages 620-627

  Hoyer, Herbert ^a   Greindl, Melanie ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Controlled release; FD4; In vivo study; Patch system; Polycarbophil cysteine

Indexed keywords

CYSTEINE; EUDRAGIT; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUTATHIONE; LACTOSE; MANNITOL; POLYCARBOPHIL; POLYMER; STARCH; SUGAR; ACRYLIC ACID RESIN; DEXTRAN; DRUG CARRIER; DRUG DERIVATIVE; EXCIPIENT; FLUORESCEIN ISOTHIOCYANATE; POLYCARBOPHIL CALCIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; TABLET FORMULATION; ADHESION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG DOSAGE FORM; EVALUATION; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; SOLUBILITY; SPRAGUE DAWLEY RAT; SWINE; TABLET;

ACRYLIC RESINS; ADHESIVENESS; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CYSTEINE; DELAYED-ACTION PREPARATIONS; DEXTRANS; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; FLUORESCEIN-5-ISOTHIOCYANATE; INJECTIONS, INTRAVENOUS; INTESTINAL MUCOSA; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SWINE; TABLETS;

EID: 59849129871     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21480     Document Type: Article

References (32)

1. Macheras P, Reppas C, Dressman JB. 1995. Biopharmaceutics of orally administered drugs. Ellis Horwood Ser Pharm Technol 1:1-2.
2. Eaimtrakarn S, Rama Prasad YV, Puthli SP, Yoshikawa Y, Shibata N, Takada K. 2003. Possibility of a patch system as a new oral delivery system. Int J Pharm 250:111-117.
3. Shen Z, Mitragotri S. 2002. Intestinal patches for oral drug delivery. Pharm Res 19:391-395.
4. Hoyer H, Föger F, Kafedjiiski K, Loretz B, Bernkop-Schnürch A. 2007. Design and evaluation of a new gastrointestinal mucoadhesive patch system containing chitosan-glutathione. Drug Dev Ind Pharm 33:1289-1296.
5. Tao SL, Desai TA. 2005. Gastrointestinal patch systems for oral drug delivery. Drug Discov Today 10:909-915.
6. Grabovac V, Föger F, Bernkop-Schnürch A. 2008. Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers. Int J Pharm 348:169-174.
7. Bernkop-Schnürch A, Schwarz V, Steininger S. 1999. Polymers with thiol groups: A new generation of mucoadhesive properties? Pharm Res 16:876-881.
8. Clausen AE, Kast CE, Bernkop-Schnürch A. 2002. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res 19:602-608.
9. Eaimtrakarn S, Itoh Y, Kishimoto JL, Yoshikawa Y, Shibata N, Takada K. 2001. Retention and transit of intestinal mucoadhesive films in the rat small intestine. Int J Pharm 224:61-67.
10. Bernkop-Schnürch A, Steininger S. 2000. Synthesis and characterization of mucoadhesive thiolated polymers. Int J Pharm 194:239-247.
11. Lieberman AH, Lachman L. 1980. Pharmaceutical dosage forms: Tablets, Vol., 1. New York: Marcel Dekker Inc. p 220.
12. Bernkop-Schnürch A, Kast CE. 2001. Thiolated polymers-thiomers: Development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345-2352.
13. Kondoh M, Takahashi A, Fujii M, Yagi K, Watanabe Y. 2006. A novel strategy for a drug delivery system using a claudin modulator. Biol Pharm Bull 29:1783-1789.
14. Nakamura K, Takayama K, Nagai T, Maitani Y. 2003. Regional intestinal absorption of FITC-Dextran 4,400 with nanoparticles based on b-Sitosterol b-D-glucoside in rats. J Pharm Sci 92:311-318.
15. Mehvar R, Shepard TL. 1991. Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. J Pharm Sci 81:908-912.
16. Werle M, Hoffer M. 2006. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111:41-46.
17. Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A. 2006. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. Biomaterials 27:5855-5860.
18. Kast CE, Guggi D, Langoth N, Bernkop-Schnürch A. 2003. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm Res 20:931-936.
19. Thaler SC, Bernkop-Schnürch A. 1999. Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems. J Pharm Sci 89:901-909.
20. Bernkop-Schnürch A. 2005. Mucoadhesive systems in oral drug delivery. Drug Discov Today: Technol 2:83-87.
21. 14C labelled poly(acrylic acids): An in vivo study. Biomaterials 22:1861-1867.
22. Whitehead K, Zancong S, Mitragotri S. 2004. Oral delivery of macromolecules using intestinal patches: Applications for insulin delivery. J Control Release 98:37-45.
23. Achleitner B. 1995. Bioadhäsive Arzneiformulierungen. Freisetzung, Stabilität und Dotierung mit Fimbrien. University of Vienna: Diplomathesis.
24. Leitner VM, Walker GF, Bernkop-Schnürch A. 2003. Thiolated polymers: Evidence for the formulation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 56:207-214.
25. Imam ME, Hornof M, Valenta C, Bernkop-Schnürch A. 2003. Evidence for the interpenetration of mucoadhesive polymers into the mucus gel layer. STP Pharma 13:171-176.
26. Bernkop-Schnürch A, Weithaler A, Albrecht K, Greimel A. 2006. Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int J Pharm 317:76-81.
27. Bernkop-Schnürch A. 2000. Chitosan and its derivates: Potential excipients for peroral peptide delivery systems. Int J Pharm 194:1-13.
28. Barrett CW, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, Chock PB. 1999. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38:6699-6705.
29. Guggi D, Bernkop-Schnürch A. 2005. Improved paracellular uptake by the combination of different types of permeation enhancers. Int J Pharm 288:141-150.
30. Kast CE, Bernkop-Schnürch A. 2002. Influence of the molecular mass on the permeation enhancing effect of different poly(acrylates). STP Pharma Sci 12:351-356.
31. Marschütz MK, Caliceti P, Bernkop-Schnürch A. 2000. Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res 17:1468-1474.
32. Swarbrick J, Boylan JC. 2002. Encyclopaedia of pharmaceutical technology, Vol. I, 2nd edition. New York: Marcel Dekker Inc. p 811.